Acciones Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Acciones
TEVA
IL0006290147
Farmacéuticos
Ventas 2024 * | 15,86 mil M 59,92 mil M 14,84 mil M | Ventas 2025 * | 16,35 mil M 61,75 mil M 15,29 mil M | Capitalización | 14,74 mil M 55,67 mil M 13,78 mil M |
---|---|---|---|---|---|
Resultado Neto 2024 * | 1538 M 5809,95 M 1438,75 M | Resultado Neto 2025 * | 1442 M 5447,3 M 1348,95 M | VE / Ventas 2024 * | 1,85 x |
Deuda neta 2024 * | 14,62 mil M 55,24 mil M 13,68 mil M | Deuda neta 2025 * | 12,12 mil M 45,78 mil M 11,34 mil M | VE / Ventas 2025 * | 1,64 x |
P/E ratio 2024 * |
10,4
x | P/E ratio 2025 * |
9,73
x | Empleados | - |
Rendimiento 2024 * |
-
| Rendimiento 2025 * |
-
| Flotante | 89,71 % |
Último transcript sobre Teva Pharmaceutical Industries Limited
Directores | Puesto | Edad | Desde |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01/01/23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22/12/19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01/09/15 |
Janet Vergis
BRD | Director/Board Member | 60 | 09/06/20 |
Sol Barer
CHM | Chairman | 76 | 01/01/15 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+25,78 % | 672 mil M | |
+25,87 % | 570 mil M | |
-5,97 % | 360 mil M | |
+16,21 % | 321 mil M | |
+8,62 % | 300 mil M | |
+7,08 % | 217 mil M | |
-9,12 % | 204 mil M | |
+5,01 % | 199 mil M | |
-9,32 % | 149 mil M |